J3030 – Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3030
- Long description
- Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- Short description
- Sumatriptan succinate / 6 mg
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1986
- Last change
- January 1, 2000 – No change
Frequently asked questions
What is HCPCS code J3030?
J3030 is a HCPCS Level II code for injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered).
Does Medicare cover J3030?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2941 – Injection, somatropin, 1 mg
- J2950 – Injection, promazine hcl, up to 25 mg
- J2993 – Injection, reteplase, 18.1 mg
- J2995 – Injection, streptokinase, per 250,000 iu
- J2997 – Injection, alteplase recombinant, 1 mg
- J2998 – Injection, plasminogen, human-tvmh, 1 mg
- J3000 – Injection, streptomycin, up to 1 gm
- J3010 – Injection, fentanyl citrate, 0.1 mg
- J3031 – Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
- J3032 – Injection, eptinezumab-jjmr, 1 mg
- J3055 – Injection, talquetamab-tgvs, 0.25 mg
- J3060 – Injection, taliglucerase alfa, 10 units
- J3070 – Injection, pentazocine, 30 mg
- J3090 – Injection, tedizolid phosphate, 1 mg
- J3095 – Injection, telavancin, 10 mg
- J3101 – Injection, tenecteplase, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.